Abnormalities in circadian blood pressure variability and endothelial function: pragmatic markers for adverse cardiometabolic profiles in asymptomatic obese adults
Tóm tắt
Cardiovascular disease (CVD) risk, although perceived to be high, is often difficult to demonstrate in disease free (healthy) obese adults. Changes in circadian blood pressure variability (CBPV) and endothelial function (EF) may be early correlates of cardiometabolic disorders. Asymptomatic men and women in 3 groups: normal weight (n = 10), overweight (n = 10) and obese (n = 15) were evaluated. Blood pressure and heart rate were recorded over 7 days: every 30 minutes during the day and every 60 minutes during the night, by automatic ambulatory monitoring. Resting EF was assessed in a fasting state between 8-10 AM by brachial ultrasound. Anthropometric and cardiometabolic indicators were measured and correlations with CBPV and EF were investigated. The 3 groups had (Mean(SD)) BMI: 22.6(1.6), 27(3) and 34(5) kg/m2, respectively, weight: 64(16), 79(14), 95(16) kg and waist circumference: 79(9), 93(10), 107(13) cm. None in normal-weight or overweight groups had abnormal CBPV, while 8 of 15 obese adults had one or more CBPV abnormities (p < 0.05). Obese adults with CBPV abnormalities had elevated hs-CRP (15.3(9.3) mg/L), fibrinogen (593(97) mg/dl), fasting serum glucose (102(16) mg/dL), and cardiac risk ratios (Total-C/HDL-C: 5.2(1.9), LDL-C/HDL-C: 3.1(1.4)). Adults in the 3 respective groups who did not have CBPV abnormalities had flow-mediated brachial artery dilatation (FMD) of 0.22(0.06); 0.20(0.04), 0.23(0.02) mm over resting diameter. Obese participants with CBPV abnormalities (Mesor-hypotension, circadian hyper amplitude tension, elevated pulse pressure), had attenuated FMD at 78, 52, and 56% of resting reference diameter (means 0.18(0.07), 0.12(0.08), and 0.13(0.05) mm; p < 0.05), respectively. Asymptomatic obese adults with abnormal CBPV and EF exhibit unfavorable cardiometabolic profiles.
Tài liệu tham khảo
Eckel RH, York DA, Rossner S, Hubbard V, Caterson I, St Jeor ST, Hayman LL, Mullis RM, Blair SN, American Heart Association: Prevention Conference VII: obesity, a worldwide epidemic related to heart disease and stroke: executive summary. Circulation. 2004, 110: 2968-2975. 10.1161/01.CIR.0000140086.88453.9A.
World Health Organization: Obesity: Preventing and managing the global epidemic. [WHO Technical report series No. 894]. 2000, Geneva. World Health Organization
Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y: Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007, 115: e69-e171. 10.1161/CIRCULATIONAHA.106.179918.
World Health Organization Web site: Cardiovascular disease: prevention and control. 2003, [http://www.who.int/dietphysicalactivity/publications/facts/cvd/en/]
Stokes J, Kannel WB, Wolf PA, Cupples LA, D'Agostino RB: The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. Circulation. 1987, 75 (6 Pt 2): V65-73.
Kannel WB, D'Agostino RB, Sullivan L, Wilson PW: Concept and usefulness of cardiovascular risk profiles. Am Heart J. 2004, 148 (1): 16-26. 10.1016/j.ahj.2003.10.022.
Juutilainen A, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Type 2 diabetes as a 'coronary heart disease equivalent': an 18-year prospective population-based study in Finnish subjects. Diabetes Care. 2005, 28: 2901-2907. 10.2337/diacare.28.12.2901.
Whiteley L, Padmanabhan S, Hole D, Isles C: Should diabetes be considered a coronary heart disease risk equivalent?: results from 25 years of follow-up in the Renfrew and Paisley survey. Diabetes Care. 2005, 28: 1588-1593. 10.2337/diacare.28.7.1588.
The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long term complications in the diabetes control in insulin dependent diabetes mellitus. N Engl J Med. 1993, 329: 977-986. 10.1056/NEJM199309303291401.
Nielson C, Lange T, Hadjokas N: Blood glucose and coronary artery disease in nondiabetic patients. Diabetes Care. 2006, 29: 998-1001. 10.2337/dc05-1902.
Schnell O, Standl E: Impaired glucose tolerance, diabetes, and cardiovascular disease. Endocr Pract. 2006, 12 (Suppl 1): 16-19.
Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, Cameron AJ, Dwyer T, Taylor HR, Tonkin AM, Wong TY, McNeil J, Shaw JE: Risk of cardiovascular and all cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation. 2007, 116: 151-157. 10.1161/CIRCULATIONAHA.106.685628.
Diamantopoulos EJ, Andreadis EA, Tsourous GI, Katsanou PM, Georgiopoulos DX, Nestora KC, Raptis SA: Early vascular lesions in subjects with metabolic syndrome and prediabetes. Int Angiol. 2006, 25: 179-183.
Meigs JB, Larson MG, D'Agostino RB, Levy D, Clouse ME, Nathan DM, Wilson PW, O'Donnell CJ: Coronary artery calcification in type 2 diabetes and insulin resistance: the Framingham offspring study. Diabetes Care. 2002, 25: 1313-1319. 10.2337/diacare.25.8.1313.
Gupta AK, Greenway FL, Cornelissen G, Pan W, Halberg F: Prediabetes is Associated with Abnormal Circadian Blood Pressure Variability. J Hum Hypertens. 2008, 22 (9): 627-33. 10.1038/jhh.2008.32.
Gupta AK, Greenway FL, Cornelissen G, Pan W, Halberg F, Gupta AK, Johnson WD: Prediabetes and prehypertension in disease free obese adults correlate with an exacerbated systemic proinflammatory milieu. J Inflamm (Lond). 2010, 7: 36-10.1186/1476-9255-7-36.
Stamler R, Stamler J, Riedlinger WF, Algera G, Roberts RH: Weight and blood pressure: findings in hypertension screening of 1 million Americans. JAMA. 1978, 240: 1607-1610. 10.1001/jama.240.15.1607.
Kashyap ML: Cholesterol and atherosclerosis: a contemporary perspective. Ann Acad Med Singapore. 1997, 26 (4): 517-23.
Kim SH, Reaven GM: The metabolic syndrome: one step forward, two steps back. Diab Vasc Dis Res. 2004, 1: 68-75. 10.3132/dvdr.2004.010.
Reaven GM: Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. Panminerva Med. 2005, 47: 201-210.
Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS: Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation. 2004, 109: 42-46. 10.1161/01.CIR.0000108926.04022.0C.
Myerburg RJ, Kessler KM, Castellanos A: Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med. 1993, 119: 1187-1197.
Michos ED, Vasamreddy CR, Becker DM, Yanek LR, Moy TF, Fishman EK, Becker LC, Blumenthal RS: Women with a low Framingham risk score and a family history of premature coronary heart disease have a high prevalence of subclinical coronary atherosclerosis. Am Heart J. 2005, 150 (6): 1276-81. 10.1016/j.ahj.2005.02.037.
Lloyd-Jones DM, Larson MG, Beiser A, Levy D: Lifetime risk of developing coronary heart disease. Lancet. 1999, 353: 89-92. 10.1016/S0140-6736(98)10279-9.
Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, Wolf PA: The lifetime risk of stroke: estimates from the Framingham Study. Stroke. 2006, 37: 345-350. 10.1161/01.STR.0000199613.38911.b2.
Standards of medical care in diabetes--2007: American Diabetes Association. Diabetes Care. 2007, 30 (Suppl 1): S4-S41.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, National Heart and Blood Institute Joint National Committee on prevention, detection, evalution, and treatment of high blood pressure; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003, 289: 2560-2572. 10.1001/jama.289.19.2560.
Otsuka K, Cornélissen G, Halberg F, Oehlerts G: Excessive circadian amplitude of blood pressure increases risk of ischaemic stroke and nephropathy. J Med Eng Technol. 1997, 21 (1): 23-30. 10.3109/03091909709030299.
Halberg F, Corne´lissen G, Katinas G, Tvildiani L, Gigolashvili M, Janashia K, Toba T, Revilla M, Regal P, Sothern RB, Wendt HW, Wang ZR, Zeman M, Jozsa R, Singh RB, Mitsutake G, Chibisov SM, Lee J, Holley D, Holte JE, Sonkowsky RP, Schwartzkopff O, Delmore P, Otsuka K, Bakken EE, Czaplicki J, International BIOCOS Group: Chronobiology's progress: season's appreciations 2004-2005. Time, frequency, phase, variable, individual, age- and site-specific chronomics. J Appl Biomed. 2006, 4: 1-38.
Corrado E, Rizzo M, Coppola G, Muratori I, Carella M, Novo S: Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study. Coron Artery Dis. 2008, 19 (3): 139-44. 10.1097/MCA.0b013e3282f3fbde.
Li C, Ford ES, McGuire LC, Mokdad AH: Increasing trends in waist circumference and abdominal obesity among US adults. Obesity (Silver Spring). 2007, 15 (1): 216-24. 10.1038/oby.2007.505.
Ghandehari H, Le V, Kamal-Bahl S, Bassin SL, Wong ND: Abdominal obesity and the spectrum of global cardiometabolic risks in US adults. Int J Obes (Lond). 2009, 33 (2): 239-48. 10.1038/ijo.2008.252.
Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, D'Agostino RB, O'Donnell CJ: Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007, 116 (1): 39-48. 10.1161/CIRCULATIONAHA.106.675355.
Berg AH, Scherer PE: Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005, 96 (9): 939-49. 10.1161/01.RES.0000163635.62927.34. Review
Inadera H: The usefulness of circulating adipokine levels for the assessment of obesity-related health problems. Int J Med Sci. 2008, 5 (5): 248-62.
Adams RJ, Appleton SL, Hill CL, Wilson DH, Taylor AW, Chittleborough CR, Gill TK, Ruffin RE: Independent Association of HbA (1c) and Incident Cardiovascular Disease in People Without Diabetes. Obesity (Silver Spring). Obesity (Silver Spring). 2009, 17 (3): 559-63. 10.1038/oby.2008.592.
Jeppesen J, Hansen TW, Olsen MH, Rasmussen S, Ibsen H, Torp-Pedersen C, Hildebrandt PR, Madsbad S: C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study. Eur J Cardiovasc Prev Rehabil. 2008, 15 (5): 594-8. 10.1097/HJR.0b013e328308bb8b.
Margolis KL, Manson JE, Greenland P, Rodabough RJ, Bray PF, Safford M, Grimm RH, Howard BV, Assaf AR, Prentice R, Women's Health Initiative Research Group: Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med. 2005, 165 (5): 500-8. 10.1001/archinte.165.5.500.
Kim SY, De Vera MA, Choi HK: Gout and mortality. Clin Exp Rheumatol. 2008, 26 (5 Suppl 5): S115-9.
Gupta AK, McGlone M, Greenway FL, Johnson WD: Prehypertension in disease-free adults: a marker for an adverse cardiometabolic risk profile. Hypertens Res. 2010, 33 (9): 905-10. 10.1038/hr.2010.91.
Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR: Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004, 110 (10): 1245-50. 10.1161/01.CIR.0000140677.20606.0E.
Takeda N, Maemura K: Circadian clock and vascular disease. Hypertens Res. 2010, 33 (7): 645-51. 10.1038/hr.2010.68.
White WB: How well does ambulatory blood pressure predict target-organ disease and clinical outcome in patients with hypertension?. Blood Press Monit. 1999, 4 (Suppl 2): S17-S21. (review)
Felício JS, de Souza AC, Kohlmann N, Kohlmann O, Ribeiro AB, Zanella MT: Nocturnal blood pressure fall as predictor of diabetic nephropathy in hypertensive patients with type 2 diabetes. Cardiovasc Diabetol. 2010, 13 (9): 36-10.1186/1475-2840-9-36.